4.7 Article

BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Miglitol, an Oral Antidiabetic Drug, Downregulates Melanogenesis in B16F10 Melanoma Cells through the PKA, MAPK, and GSK3β/β-Catenin Signaling Pathways

Hyeon-Mi Kim et al.

Summary: The antidiabetic drug miglitol can be repurposed as an effective cosmeceutical agent for the treatment of hyperpigmentation. It reduces melanin production and tyrosinase activity in melanoma cells, and regulates melanogenesis through the PKA, MAPK, and GSK3 beta/beta-Catenin signaling pathways. In human skin tests, miglitol displayed no adverse reactions, indicating its potential for treating hyperpigmentation symptoms.

MOLECULES (2023)

Article Chemistry, Medicinal

Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents

Pasquale Linciano et al.

Summary: In this study, novel benzylpiperidine/benzylpiperazine-based compounds were designed and tested as Sigma-1 receptor (S1R) agonists. The compounds 6b and 8b showed high affinity for S1R and selectivity over S2R and NMDAR. They exhibited neuroprotective activity and enhanced neurite outgrowth in cell lines, as well as good efficacy/safety profile in in-vitro and in-vivo models. These results encourage further preclinical investigations of compounds 6b and 8b on neurodegenerative diseases.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Contribution of endoplasmic reticulum stress, MAPK and PI3K/Akt pathways to the apoptotic death induced by a penicillin derivative in melanoma cells

Yanina Bellizzi et al.

Summary: TAP7f induces apoptotic cell death in melanoma cells by inducing ER stress and activating p38, JNK, and PI3K-I/Akt pathways.

APOPTOSIS (2022)

Article Oncology

Neochamaejasmine A Promotes Apoptosis and Cell Cycle Arrest in B16F10 Melanoma Cells via JNK and p38 MAPK Signaling Pathway

Xiaoyu Chen et al.

Summary: The study found that Neochamaejasmine A (NCA) can induce apoptosis and cell cycle arrest in B16F10 melanoma cells by activating the JNK and p38 MAPK signaling pathways.

RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2022)

Article Cell Biology

RIG-I acts as a tumor suppressor in melanoma via regulating the activation of the MKK/p38MAPK signaling pathway

Rui Guo et al.

Summary: This study found that RIG-I suppresses the development of melanoma by regulating the activity of the MKK/p38 MAPK signaling pathway, suggesting it as a potential therapeutic target for this malignant disease.

HUMAN CELL (2022)

Article Dermatology

Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040

Melina Arnold et al.

Summary: Despite preventable cases, cutaneous melanoma remains the most serious skin cancer worldwide. Understanding the scale and profile of the disease is crucial to focus and strengthen global prevention efforts. The study reveals that melanoma is more frequent among males and is estimated to significantly increase by 2040 if current rates continue.

JAMA DERMATOLOGY (2022)

Article Medicine, General & Internal

EphA3 targeted by miR-3666 contributes to melanoma malignancy via activating ERK1/2 and p38 MAPK pathways

Di Ming et al.

Summary: In this study, the authors found that EphA3 is upregulated and miR-3666 is downregulated in melanoma. Inhibiting EphA3 can suppress cell proliferation and migration, as well as retard tumor growth in vivo. miR-3666 can weaken melanoma cell proliferation and migration by targeting EphA3. The miR-3666/EphA3 axis may represent a potential target for treating melanoma.

OPEN MEDICINE (2022)

Article Oncology

The State of Melanoma: Emergent Challenges and Opportunities

Michael B. Atkins et al.

Summary: MRF conducted an assessment of challenges and opportunities in melanoma research community and patients five years ago, significant progress has been made since then. However, high incidence, recurrence, and death rates for melanoma remain. The Scientific Advisory Council and Breakthrough Consortium reconvened to discuss thematic areas essential to melanoma researchers and patients, helping to understand the challenges and opportunities facing the broader melanoma community today.

CLINICAL CANCER RESEARCH (2021)

Article Cell Biology

Sphingosine-1 phosphate induces cAMP/PKA-independent phosphorylation of the cAMP response element-binding protein (CREB) in granulosa cells

Elia Paradiso et al.

Summary: This study demonstrates that SIP may induce cAMP-independent activation of pCREB in granulosa cells, although this is insufficient to induce intracellular steroidogenic signals and progesterone synthesis. The activation of S1P-S1PR axis may cooperate with gonadotropins in modulating follicle development.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)

Article Chemistry, Medicinal

Sigma-1 and Sigma-2 Receptor Modulators as Potential Therapeutics for Alzheimer’s Disease

Robert B. Kargbo

ACS Medicinal Chemistry Letters (2021)

Article Biochemistry & Molecular Biology

Study of the Relationship between Sigma Receptor Expression Levels and Some Common Sigma Ligand Activity in Cancer Using Human Cancer Cell Lines of the NCI-60 Cell Line Panel

Evangelia Sereti et al.

Summary: This study aimed to investigate the expression levels of both sigma receptor subtypes in several human cancer cell lines and study their relationship with the activity of sigma ligands. Through in vitro experiments and the NCI60 COMPARE algorithm, the cytotoxic mechanism of action of the selected sigma ligands studied herein was further elucidated.

BIOMEDICINES (2021)

Article Multidisciplinary Sciences

Structures of the σ2, receptor enable docking for bioactive ligand discovery

Assaf Alon et al.

Summary: The study determined the crystal structure of sigma(2) receptor with roluperidone and PB28, identified new chemical compounds with higher affinities, and confirmed the role of sigma(2) receptor in pain perception, highlighting the potential for developing new pain treatments.

NATURE (2021)

Article Oncology

Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models

Mauro Niso et al.

Summary: The novel sigma-2 receptor targeting thiosemicarbazone, FA4, showed more potent cytotoxicity in pancreatic cancer cells compared to previously studied thiosemicarbazones (MLP44, PS3, ACthio-1). It activated pro-apoptotic pathways and decreased autophagy, holding promise for developing more efficient therapies targeting specific characteristics of individual tumor types.

CELLULAR ONCOLOGY (2021)

Article Pharmacology & Pharmacy

Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity

Cheri Z. Liu et al.

Summary: The Sigma-2 receptor is upregulated in cancer cells compared to normal cells, and traditional Sigma-2 receptor agonists can induce apoptosis and autophagy, with recent research suggesting a metabolic stimulative function as well. This study compared the activities of two related compounds, CM571 and MAM03055A, showing that CM571 induces metabolic stimulation while MAM03055A potently induces cell death in various cancer cell lines by binding preferentially to sigma-2 receptors. Additionally, MAM03055A exhibited pseudo-irreversible binding to sigma-2 receptors and caused a time-dependent loss of the receptor protein from cells, indicating divergent effects compared to CM571.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Article Chemistry, Medicinal

Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective

Antonino N. Fallica et al.

Summary: Sigma receptors have been found to play a significant role in cancer growth and cell proliferation. Recent research focuses on developing selective sigma receptor ligands with potential anti-tumor properties. Studies in medicinal chemistry provide insights into the structure-activity relationships of selective sigma receptor ligands.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Oncology

Metformin promotes anticancer activity of NK cells in a p38 MAPK dependent manner

Wenjiao Xia et al.

Summary: Metformin enhances the cytolytic activity of NK cells by activating the JAK and AKT signaling pathways, leading to improved cancer surveillance and therapy response rates in vivo. It also increases NK cell and T cell infiltration in tumors, providing potential for metformin in cancer treatment strategies.

ONCOIMMUNOLOGY (2021)

Article Dermatology

Inhibition of p38/MK2 Signaling Prevents Vascular Invasion of Melanoma

Judith Wenzina et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Breast Cancer 18F-ISO-1 Uptake as a Marker of Proliferation Status

Elizabeth S. McDonald et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

Article Biochemistry & Molecular Biology

Inhibitory Effects of Pinostilbene Hydrate on Melanogenesis in B16F10 Melanoma Cells via ERK and p38 Signaling Pathways

You Chul Chung et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Oncology

Apigenin induces apoptosis by regulating Akt and MAPK pathways in human melanoma cell A375SM

Joong-Seok Woo et al.

MOLECULAR MEDICINE REPORTS (2020)

Article Biochemistry & Molecular Biology

Identification of a Potent and Selective 5-HT1A Receptor Agonist with In Vitro and In Vivo Antinociceptive Activity

Pasquale Linciano et al.

ACS CHEMICAL NEUROSCIENCE (2020)

Article Pharmacology & Pharmacy

Antitumor and apoptotic effects of quercetin on human melanoma cells involving JNK/P38 MAPK signaling activation

Sung-Hyun Kim et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2019)

Article Biochemistry & Molecular Biology

Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury

Edwin Vazquez-Rosa et al.

ACS CHEMICAL NEUROSCIENCE (2019)

Article Cell Biology

TMEM97 and PGRMC1 do not mediate sigma-2 ligand-induced cell death

Chenbo Zeng et al.

CELL DEATH DISCOVERY (2019)

Letter Neurosciences

Core-rod myopathy due to a novel mutation in BTB/POZ domain of KBTBD13 manifesting as late onset LGMD

Matteo Garibaldi et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)

Review Pharmacology & Pharmacy

TMEM Proteins in Cancer: A Review

Kathleen Schmit et al.

FRONTIERS IN PHARMACOLOGY (2018)

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Multidisciplinary Sciences

Identification of the gene that codes for the σ2 receptor

Assaf Alon et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Review Oncology

The Role of Cholesterol in Cancer

Omer F. Kuzu et al.

CANCER RESEARCH (2016)

Article Multidisciplinary Sciences

Crystal structure of the human σ1 receptor

Hayden R. Schmidt et al.

NATURE (2016)

Article Pharmacology & Pharmacy

Blockade of Cocaine or σ Receptor Agonist Self Administration by Subtype-Selective σ Receptor Antagonists

Jonathan L. Katz et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)

Article Pharmacology & Pharmacy

Elements in support of the 'non-identity' of the PGRMC1 protein with the σ2 receptor

Carmen Abate et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2015)

Article Chemistry, Medicinal

Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α<alpha>1 and 5-HT1A receptors

Silvia Franchini et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)

Review Biochemistry & Molecular Biology

ER stress-induced cell death mechanisms

Renata Sano et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)

Article Chemistry, Medicinal

The σ2 Receptor: A Novel Protein for the Imaging and Treatment of Cancer

Robert H. Mach et al.

JOURNAL OF MEDICINAL CHEMISTRY (2013)

Review Biochemistry & Molecular Biology

Endoplasmic reticulum stress and lipid dysregulation

Stephen M. Colgan et al.

EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)

Review Pharmacology & Pharmacy

The sigma-1 receptor chaperone as an inter-organelle signaling modulator

Tsung-Ping Su et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2010)

Article Cell Biology

Identification of Cholesterol-Regulating Genes by Targeted RNAi Screening

Fabian Bartz et al.

CELL METABOLISM (2009)

Article Chemistry, Multidisciplinary

AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility

Garrett M. Morris et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)

Article Biochemical Research Methods

OPM: Orientations of proteins in membranes database

MA Lomize et al.

BIOINFORMATICS (2006)

Review Chemistry, Multidisciplinary

GROMACS: Fast, flexible, and free

D Van der Spoel et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)

Article Biochemistry & Molecular Biology

Involvement of ERK MAP kinase in endoplasmic reticulum stress in SH-SY5Y human neuroblastoma cells

K Arai et al.

JOURNAL OF NEUROCHEMISTRY (2004)

Article Biochemistry & Molecular Biology

DNA microarrays identification of primary and secondary target genes regulated by p53

K Kannan et al.

ONCOGENE (2001)